Elucidating the Pro‐Tumor Role of LncRNA CROCCP2 in Glioma via the miR ‐5584‐5p/ HOXD11 /Autophagy Pathway
Cancer Science · 2026
DOI: 10.1111/cas.70433 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, 2026. Verfasst von Feng Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: The First Department of Neurosurgery, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China. Hauptthemen laut MEDLINE: RNA, Long Noncoding, MicroRNAs, Autophagy, Glioma. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: First-Class Discipline Team of Kunming Medical University, Yunnan Fundamental Research Kunming Medical University Projects, National Natural Science Foundation of China.
Abstract (Originalsprache)
Glioma is the most common primary malignant tumor of the central nervous system, characterized by high invasiveness and a high recurrence rate. The clinical therapeutic efficacy remains limited, necessitating the exploration of novel molecular mechanisms and therapeutic targets. Long non‐coding RNAs (lncRNAs), as key epigenetic regulators in tumor progression, can influence tumorigenesis and development through lncRNA–miRNA–mRNA regulatory axes. Here, we reveal the critical role of the lncRNA CROCCP2/miR‐5584‐5p/HOXD11 axis in glioma. LncRNA CROCCP2 was significantly upregulated in glioma tissues and cell lines, in vitro, markedly promoting the proliferation, migration, and invasion of glioma cells. Mechanistically, LncRNACROCCP2 acts as a competing endogenous RNA to sponge miR‐5584‐5p, thereby relieving its suppression of the target gene HOXD11, leading to HOXD11 upregulation. HOXD11 negatively regulated autophagy, as reflected by reduced LC3B‐II and Beclin1 levels and increased p62 expression. Conversely, CROCCP2 or HOXD11 knockdown activated autophagy and provided supportive evidence for ongoing autophagic flux based on the addition of LC3B‐II and p62 after bafilomycin A1 treatment. Knockdown of either lncRNA CROCCP2 or HOXD11 suppressed glioma cell proliferation, migration, and invasion in vitro. In addition, HOXD11 silencing markedly inhibited subcutaneous and intracranial tumor growth in nude mice; furthermore, HOXD11 knockout can even halt the growth of subcutaneous tumors. Collectively, our findings suggest that the lncRNA CROCCP2/miR‐5584‐5p/HOXD11 axis contributes to glioma cell malignant phenotypes in vitro and tumor growth in vivo, at least partly through negative regulation of autophagy, providing a potential molecular target for glioma therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Department of Neurosurgery, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
- Department of Animal Zoology, Kunming Medical University, Kunming, Yunnan, China.
- Basic Medical School, Kunming Medical University, Kunming, Yunnan, China.
ORCID-Profile: Jia Liu
Förderung
- First-Class Discipline Team of Kunming Medical University
- Yunnan Fundamental Research Kunming Medical University Projects
- National Natural Science Foundation of China
Zitieren
APA
Wang, F., Lei, G., Peng, Y., Liu, M., Jiang, T., Wang, M., Wang, Z., Pu, J., & Liu, J. (2026). Elucidating the Pro‐Tumor Role of LncRNA CROCCP2 in Glioma via the miR ‐5584‐5p/ HOXD11 /Autophagy Pathway. Cancer Science. https://doi.org/10.1111/cas.70433
Vancouver
Wang F, Lei G, Peng Y, Liu M, Jiang T, Wang M, et al. Elucidating the Pro‐Tumor Role of LncRNA CROCCP2 in Glioma via the miR ‐5584‐5p/ HOXD11 /Autophagy Pathway. Cancer Science. 2026. doi:10.1111/cas.70433
BibTeX
@article{Wang2026,
author = {Wang, Feng and Lei, Ganni and Peng, Yuan and Liu, Maoqiao and Jiang, Tianqi and Wang, Minghui and Wang, Zhe and Pu, Jun and Liu, Jia},
title = {Elucidating the Pro‐Tumor Role of LncRNA CROCCP2 in Glioma via the miR ‐5584‐5p/ HOXD11 /Autophagy Pathway},
journal = {Cancer Science},
year = {2026},
doi = {10.1111/cas.70433}
}
EUVIMED